Annual Fee Adjustments for Drugs and Medical Devices
The annual Consumer Price Index (CPI) has been calculated at 1.7%. Therefore, the current fees for the following cost-recovered items will be adjusted as of April 1, 2026: Drug […]
The annual Consumer Price Index (CPI) has been calculated at 1.7%. Therefore, the current fees for the following cost-recovered items will be adjusted as of April 1, 2026: Drug […]
The Web PLA and ANF have been updated and are now available on-line. The Pause in processing submission targeted between December 1st and 15th had ended. The improvements to the […]

Published on December 3rd, the Red Tape Reduction Office published their themes to focus on system-wide opportunities to simplify regulation and reduce costs for Canadian and businesses under their Horizontal […]
The never-ending saga of Forward Regulatory Plans was released on Monday December 15th. The current plans include various Departments with Health Canada and ECCC. Of importance to our membership are: […]

Cosmetics Alliance attended these meetings, along with your PCMA and FCM Committee Chairs and Vice-Chairs on December 9th and 11th. The intent of these sessions was for Health Canada […]

The US FDA issued a proposed rule entitled “Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products” as part of its implementation of the Modernization of Cosmetics Regulation […]

Based on data reviewed by the US FDA, this ingredient provides protection against both UV A and B rays, has low levels of absorption through the skin and rarely causes […]

The December 2025 issue of the Workplace Hazardous Products Program (WHPP) newsletter is now available! This issue shares updates, such as a summary of the recent November 2025 WHPP multi-stakeholder […]

On December 15, we were advised that the Substance Search Tool has been updated to include a new list. The list “Recently Published Notices under Section 71 of Canadian Environmental […]

Canada’s Chemicals Management Plan (CMP) program has shared the following Risk Assessment Publication Plan to inform stakeholders and interested parties of upcoming publications. The targeted publication dates are subject to […]